TriSalus Life Sciences Inc
Research TriSalus Life Sciences Inc (TLSI) on Bullrun: market cap USD 309.19M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTLSI
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 309.19M
- Financial periodQ2 2026
- RevenueUSD 11.41M
- Net income-USD 9.19M
- Free cash flow-USD 10.21M
- Gross margin86.8%
Valuation Snapshot
latest market cap is USD 309.19M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 45.15M | -USD 39.23M | -USD 18.93M | 84.6% | -1.84 | USD 20.44M | USD 33.05M | -USD 33.86M |
| FY2024 | USD 29.43M | -USD 30.05M | -USD 41.19M | 86.1% | -1.31 | USD 8.53M | USD 22.08M | -USD 25.89M |
| FY2023 | USD 18.51M | -USD 59.36M | -USD 51.17M | 85.9% | -6.77 | USD 11.78M | USD 0 | -USD 27.07M |
| FY2022 | USD 12.40M | -USD 47.19M | -USD 32.97M | 81.8% | -161.55 | USD 9.41M | n/a | -USD 177.13M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 309.19M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 348.98M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 156.71M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 223.19M | n/a | n/a | n/a |
| 2022 | 2022-09-29 | n/a | 31.1 | n/a | n/a |
| 2021 | 2021-12-31 | n/a | 65.9 | n/a | n/a |
About TriSalus Life Sciences Inc
TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States. It offers Pressure-Enabled Drug Delivery (PEDD) infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is TriSalus Life Sciences Inc's market cap?
TriSalus Life Sciences Inc's market capitalization is USD 309.19M.
What does TriSalus Life Sciences Inc do?
TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States.